These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 33799178

  • 1. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
    Amin KM, Abdel Rahman DE, Abdelrasheed Allam H, El-Zoheiry HH.
    Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB, Palaka BK, Penumala M, Kotapati KV, Devineni SR, Eadlapalli S, Darla MM, Ampasala DR, Vadde R, Amooru GD.
    Eur J Med Chem; 2016 Jan 01; 107():219-32. PubMed ID: 26588065
    [Abstract] [Full Text] [Related]

  • 3. Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation.
    Hasan AH, Murugesan S, Amran SI, Chander S, Alanazi MM, Hadda TB, Shakya S, Pratama MRF, Das B, Biswas S, Jamalis J.
    Bioorg Chem; 2022 Feb 01; 119():105572. PubMed ID: 34971946
    [Abstract] [Full Text] [Related]

  • 4. Neurobehavioral investigation and acetylcholinesterase inhibitory activity study for some new coumarin derivatives.
    Mahmoud WR, Nissan YM, Elsawah MM, Refaey RH, Ragab MF, Amin KM.
    Eur J Med Chem; 2019 Nov 15; 182():111651. PubMed ID: 31479975
    [Abstract] [Full Text] [Related]

  • 5. Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer's Disease.
    Saeedi M, Rastegari A, Hariri R, Mirfazli SS, Mahdavi M, Edraki N, Firuzi O, Akbarzadeh T.
    Chem Biodivers; 2020 May 15; 17(5):e1900746. PubMed ID: 32154628
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors.
    Sonmez F, Zengin Kurt B, Gazioglu I, Basile L, Dag A, Cappello V, Ginex T, Kucukislamoglu M, Guccione S.
    J Enzyme Inhib Med Chem; 2017 Dec 15; 32(1):285-297. PubMed ID: 28097911
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and anticholinesterase activity of coumarin-3-carboxamides bearing tryptamine moiety.
    Ghanei-Nasab S, Khoobi M, Hadizadeh F, Marjani A, Moradi A, Nadri H, Emami S, Foroumadi A, Shafiee A.
    Eur J Med Chem; 2016 Oct 04; 121():40-46. PubMed ID: 27214510
    [Abstract] [Full Text] [Related]

  • 8. 3-Aryl Coumarin Derivatives Bearing Aminoalkoxy Moiety as Multi-Target-Directed Ligands against Alzheimer's Disease.
    Abdshahzadeh H, Golshani M, Nadri H, Saberi Kia I, Abdolahi Z, Forootanfar H, Ameri A, Tüylü Küçükkılınç T, Ayazgok B, Jalili-Baleh L, Sadat Ebrahimi SE, Moghimi S, Haririan I, Khoobi M, Foroumadi A.
    Chem Biodivers; 2019 May 04; 16(5):e1800436. PubMed ID: 30957958
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS, Zhang T, Liu Y, Yang J, Xie SS, Liu J, Miao ZY, Ding Y.
    Eur J Med Chem; 2017 Jun 16; 133():184-196. PubMed ID: 28388521
    [Abstract] [Full Text] [Related]

  • 10. Coumarin derivatives as potential inhibitors of acetylcholinesterase: Synthesis, molecular docking and biological studies.
    Singla S, Piplani P.
    Bioorg Med Chem; 2016 Oct 01; 24(19):4587-4599. PubMed ID: 27519464
    [Abstract] [Full Text] [Related]

  • 11. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
    Babaee S, Chehardoli G, Akbarzadeh T, Zolfigol MA, Mahdavi M, Rastegari A, Homayouni Moghadam F, Najafi Z.
    Chem Biodivers; 2021 Jun 01; 18(6):e2000924. PubMed ID: 33861892
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and evaluation of substituted 4-methyl-2-oxo-2H-chromen-7-yl phenyl carbamates as potent acetylcholinesterase inhibitors and anti- amnestic agents.
    Anand P, Singh B.
    Med Chem; 2013 Aug 01; 9(5):694-702. PubMed ID: 23072555
    [Abstract] [Full Text] [Related]

  • 13. Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives.
    Montanari S, Bartolini M, Neviani P, Belluti F, Gobbi S, Pruccoli L, Tarozzi A, Falchi F, Andrisano V, Miszta P, Cavalli A, Filipek S, Bisi A, Rampa A.
    ChemMedChem; 2016 Jun 20; 11(12):1296-308. PubMed ID: 26507467
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
    Razavi SF, Khoobi M, Nadri H, Sakhteman A, Moradi A, Emami S, Foroumadi A, Shafiee A.
    Eur J Med Chem; 2013 Jun 20; 64():252-9. PubMed ID: 23644208
    [Abstract] [Full Text] [Related]

  • 15. Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids.
    Najafi Z, Saeedi M, Mahdavi M, Sabourian R, Khanavi M, Tehrani MB, Moghadam FH, Edraki N, Karimpor-Razkenari E, Sharifzadeh M, Foroumadi A, Shafiee A, Akbarzadeh T.
    Bioorg Chem; 2016 Aug 20; 67():84-94. PubMed ID: 27289559
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S, Ghobadian R, Mahdavi M, Nadri H, Moradi A, Akbarzadeh T, Najafi Z, Sharifzadeh M, Edraki N, Moghadam FH, Amini M.
    Daru; 2020 Dec 20; 28(2):463-477. PubMed ID: 32372339
    [Abstract] [Full Text] [Related]

  • 17. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
    Makhaeva GF, Lushchekina SV, Kovaleva NV, Yu Astakhova T, Boltneva NP, Rudakova EV, Serebryakova OG, Proshin AN, Serkov IV, Trofimova TP, Tafeenko VA, Radchenko EV, Palyulin VA, Fisenko VP, Korábečný J, Soukup O, Richardson RJ.
    Bioorg Chem; 2021 Jul 20; 112():104974. PubMed ID: 34029971
    [Abstract] [Full Text] [Related]

  • 18. Discovery of Potent Dual Binding Site Acetylcholinesterase Inhibitors via Homo- and Heterodimerization of Coumarin-Based Moieties.
    Pisani L, Catto M, De Palma A, Farina R, Cellamare S, Altomare CD.
    ChemMedChem; 2017 Aug 22; 12(16):1349-1358. PubMed ID: 28570763
    [Abstract] [Full Text] [Related]

  • 19. Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer's disease: Design, synthesis and biological evaluations.
    Singh M, Kaur M, Singh N, Silakari O.
    Bioorg Med Chem; 2017 Dec 15; 25(24):6273-6285. PubMed ID: 29089261
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and biological evaluation of edaravone derivatives bearing the N-benzyl pyridinium moiety as multifunctional anti-Alzheimer's agents.
    Zondagh LS, Malan SF, Joubert J.
    J Enzyme Inhib Med Chem; 2020 Dec 15; 35(1):1596-1605. PubMed ID: 32779503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.